glioblastoma

简明释义

英[ˌɡlaɪəʊblæsˈtəʊmə]美[ˌɡlɪoʊblæˈstoʊmə]

n. 恶性胶质瘤；成胶质细胞瘤

英英释义

单词用法

同义词

反义词

例句

1.At present time, the therapy of glioblastoma, especially the malignant glioblastoma is very difficulty.

目前，胶质瘤特别是恶性胶质瘤的治疗还是一个非常棘手的问题。

2.Remove as much of the glioblastoma tumor tissue [pink] as is safe.

保证安全的情况下删除尽可能多的脑肿瘤组织[粉红色]。

3.This may supply the new target point and strategy for the apoptosis-induced therapy of glioblastoma.

这可能为胶质母细胞瘤的凋亡诱导治疗提供新的靶点和新的策略。

4.At present time, the therapy of glioblastoma, especially the malignant glioblastoma is very difficulty.

目前，胶质瘤特别是恶性胶质瘤的治疗还是一个非常棘手的问题。

5.Glioblastoma is regarded as the most malignant form of brain tumor.

胶质母细胞瘤被认为是最恶性的脑肿瘤。

6.A diagnosis of glioblastoma is a death sentence.

胶质细胞瘤的确诊就像是一纸死刑判决书。

7.Your husband has glioblastoma, which is the worst form of brain cancer.

你的丈夫患上了胶质母细胞瘤，是脑癌中最糟的一种。

8.The most common glioma is glioblastoma multiforme and the possible causes are not fully understood.

最常见的神经胶质瘤为神经胶母细胞瘤，神经胶质瘤形成的因素至今尚未完全明朗。

9.Patients with glioblastoma (胶质母细胞瘤) often experience severe headaches and neurological symptoms.

患有glioblastoma（胶质母细胞瘤）的患者常常会出现严重的头痛和神经系统症状。

10.The survival rate for glioblastoma (胶质母细胞瘤) patients is typically low, highlighting the need for research.

患有glioblastoma（胶质母细胞瘤）的患者生存率通常较低，这突显了研究的必要性。

11.Clinical trials are underway to find new therapies for glioblastoma (胶质母细胞瘤).

临床试验正在进行中，以寻找针对glioblastoma（胶质母细胞瘤）的新疗法。

12.Research indicates that glioblastoma (胶质母细胞瘤) has a poor prognosis, often requiring aggressive treatment.

研究表明，glioblastoma（胶质母细胞瘤）预后不良，通常需要积极治疗。

13.The doctor diagnosed the patient with glioblastoma (胶质母细胞瘤) after reviewing the MRI results.

医生在查看MRI结果后，诊断患者患有glioblastoma（胶质母细胞瘤）。

作文

Glioblastoma is one of the most aggressive types of brain cancer, characterized by rapid growth and a tendency to invade surrounding brain tissue. This type of tumor arises from glial cells, which are supportive cells in the nervous system. The term glioblastoma refers specifically to a highly malignant form of glioma, and it is often diagnosed in adults between the ages of 45 and 70. The prognosis for patients with glioblastoma is generally poor, with a median survival rate of only about 15 months after diagnosis, even with aggressive treatment options such as surgery, radiation, and chemotherapy.The symptoms of glioblastoma can vary widely depending on the tumor's location within the brain. Common signs include persistent headaches, seizures, cognitive impairments, and changes in personality or behavior. Many patients initially seek medical attention due to these alarming symptoms, which can significantly impact their quality of life. Early detection is crucial, yet challenging, as the symptoms often mimic those of other neurological conditions.Treatment for glioblastoma typically involves a multi-faceted approach. Surgical resection is usually the first line of treatment, aiming to remove as much of the tumor as possible. However, complete removal is often not feasible due to the infiltrative nature of the tumor. Following surgery, patients often undergo radiation therapy and chemotherapy to target any remaining cancer cells. Temozolomide, an oral chemotherapy drug, is commonly used in conjunction with radiation.Research into glioblastoma is ongoing, with scientists exploring various new treatment modalities, including targeted therapies and immunotherapy. These innovative approaches aim to improve outcomes for patients who currently have limited options. Clinical trials are also available for eligible patients, providing access to cutting-edge treatments that may offer hope where traditional therapies have failed.Living with glioblastoma poses significant challenges, not only for the patients but also for their families. The emotional and psychological toll of this diagnosis can be overwhelming. Support systems, including counseling and support groups, play a vital role in helping patients and their loved ones navigate this difficult journey. Palliative care is also an essential component of treatment, focusing on improving the quality of life by managing symptoms and providing emotional support.In conclusion, glioblastoma is a formidable opponent in the realm of oncology, presenting numerous challenges for both patients and healthcare providers. With continued research and advancements in treatment strategies, there is hope for better outcomes in the future. Awareness and education about glioblastoma are critical in fostering early detection and improving the overall prognosis for those affected by this devastating disease.

胶质母细胞瘤是最具侵袭性的脑癌类型之一，其特征是快速生长和倾向于侵犯周围脑组织。这种类型的肿瘤起源于胶质细胞，胶质细胞是神经系统中的支持细胞。术语glioblastoma专指一种高度恶性的胶质瘤，通常在45至70岁之间的成年人中被诊断。对于glioblastoma患者的预后通常较差，诊断后的中位生存率仅约为15个月，即使采用手术、放疗和化疗等积极治疗方案。glioblastoma的症状因肿瘤在大脑中的位置而异。常见症状包括持续性头痛、癫痫发作、认知障碍以及性格或行为的变化。许多患者最初因这些令人担忧的症状寻求医疗帮助，这些症状可能会显著影响他们的生活质量。早期检测至关重要，但具有挑战性，因为症状通常与其他神经疾病相似。glioblastoma的治疗通常涉及多方面的方法。外科切除通常是治疗的第一步，旨在尽可能多地去除肿瘤。然而，由于肿瘤的浸润性特征，完全切除通常不可行。手术后，患者通常接受放疗和化疗，以针对任何残留的癌细胞。Temozolomide是一种口服化疗药物，通常与放疗联合使用。对glioblastoma的研究仍在进行中，科学家们正在探索各种新治疗方法，包括靶向治疗和免疫疗法。这些创新的方法旨在改善当前选择有限的患者的结果。临床试验也为符合条件的患者提供，提供接触前沿治疗的机会，这可能在传统疗法失败的情况下带来希望。与glioblastoma共存带来了重大挑战，不仅对患者，也对他们的家庭。这一诊断所带来的情感和心理压力可能是压倒性的。支持系统，包括咨询和支持小组，在帮助患者及其亲人应对这一艰难旅程中发挥着至关重要的作用。缓和护理也是治疗的重要组成部分，专注于通过管理症状和提供情感支持来改善生活质量。总之，glioblastoma在肿瘤学领域是一个强大的对手，对患者和医疗提供者都提出了许多挑战。随着研究的不断深入和治疗策略的进步，未来有望实现更好的结果。提高对glioblastoma的认识和教育对于促进早期检测和改善受此疾病影响的整体预后至关重要。